+499.5%
MRNA vs LBRT
+100.7%
+398.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LBRT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.0% | -3.3% | -2.1% |
| 7D | +5.5% | +8.3% | -2.8% | +6.5% |
| 30D | +158.7% | +6.1% | +152.6% | +155.9% |
| 3M | +182.1% | -34.8% | +216.9% | +192.1% |
| 6M | +151.8% | -24.8% | +176.6% | +155.6% |
| YTD | +393.6% | +12.2% | +381.3% | +378.8% |
| 1Y | +499.5% | +94.0% | +405.5% | +467.3% |
| All | +499.5% | +100.7% | +398.7% | +467.3% |
Cumulative growth
Daily Returns
Daily percentage return beside LBRT.
Daily Out/Under-Performance
Portfolio return minus LBRT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LBRT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LBRT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling